메뉴 건너뛰기




Volumn 23, Issue 5, 2002, Pages 790-793

Effects of control of home systolic blood pressure on urinary albumin excretion in patients with essential hypertension - Preliminary results of the HOSP sub-study

Author keywords

Amlodipine; Essential hypertension; Home blood pressure; Losartan; Urinary albumin excretion

Indexed keywords

ALBUMIN; AMLODIPINE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; LOSARTAN;

EID: 0036033440     PISSN: 02898020     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper
Times cited : (1)

References (15)
  • 1
    • 0032746704 scopus 로고    scopus 로고
    • Microalbuminuria in essential hypertension: Significance, pathophysiology, and therapeutic implications
    • Bianchi S, Bigazzi R, Campese VM. Microalbuminuria in essential hypertension: Significance, pathophysiology, and therapeutic implications. Am J Kidney Dis 1999;34:973-95.
    • (1999) Am J Kidney Dis , vol.34 , pp. 973-995
    • Bianchi, S.1    Bigazzi, R.2    Campese, V.M.3
  • 2
    • 0006415693 scopus 로고    scopus 로고
    • Clinical value of microalbuminuria in hypertension
    • Rosa TT, Palatini P. Clinical value of microalbuminuria in hypertension. J Hypertens 2000;18:645-54.
    • (2000) J Hypertens , vol.18 , pp. 645-654
    • Rosa, T.T.1    Palatini, P.2
  • 3
    • 0000116576 scopus 로고
    • Relation of office and home blood pressure to left ventricular hypertrophy and performance in patients with hypertension
    • Abe H, Yokouchi M, Nagata S, Ashida T, Yoshimi H, Kawano Y, et al. Relation of office and home blood pressure to left ventricular hypertrophy and performance in patients with hypertension. High Blood Press 1992;1:279-85.
    • (1992) High Blood Press , vol.1 , pp. 279-285
    • Abe, H.1    Yokouchi, M.2    Nagata, S.3    Ashida, T.4    Yoshimi, H.5    Kawano, Y.6
  • 5
    • 0005158182 scopus 로고    scopus 로고
    • Japanese source
  • 6
    • 0032810395 scopus 로고    scopus 로고
    • Elevated systolic blood pressure as a risk factor for cardiovascular and renal disease
    • He J, Whelton PK. Elevated systolic blood pressure as a risk factor for cardiovascular and renal disease. J Hypertens 1999;17(Suppl 2):S7-13.
    • (1999) J Hypertens , vol.17 , Issue.SUPPL. 2
    • He, J.1    Whelton, P.K.2
  • 7
    • 0028151603 scopus 로고
    • Ambulatory 24-hour blood pressure versus self-measured blood pressure in pharmacologic trials
    • Mengden T, Weisser B, Vetter V. Ambulatory 24-hour blood pressure versus self-measured blood pressure in pharmacologic trials. J Cardiovasc Pharmacol 1994; 24(Suppl 2):S20-5.
    • (1994) J Cardiovasc Pharmacol , vol.24 , Issue.SUPPL. 2
    • Mengden, T.1    Weisser, B.2    Vetter, V.3
  • 8
    • 0031843971 scopus 로고    scopus 로고
    • Effects of magnesium supplementation in hypertensive patients: Assessment by office, home, and ambulatory blood pressures
    • Kawano Y, Matsuoka H, Takishita S, Omae T. Effects of magnesium supplementation in hypertensive patients: Assessment by office, home, and ambulatory blood pressures. Hypertension 1998;32:260-5.
    • (1998) Hypertension , vol.32 , pp. 260-265
    • Kawano, Y.1    Matsuoka, H.2    Takishita, S.3    Omae, T.4
  • 9
    • 0033545191 scopus 로고    scopus 로고
    • Current strategies for management of hypertensive renal disease
    • Moore MA, Epstein M, Agodoa L, Dworkin LD. Current strategies for management of hypertensive renal disease. Arch Intern Med 1999;159:23-8.
    • (1999) Arch Intern Med , vol.159 , pp. 23-28
    • Moore, M.A.1    Epstein, M.2    Agodoa, L.3    Dworkin, L.D.4
  • 10
    • 0027235343 scopus 로고
    • Microalbuminuria in essential hypertension: Reduction by different antihypertensive drugs
    • Erley CM, Haefere U, Heyne N, Braun N, Risler T. Microalbuminuria in essential hypertension: Reduction by different antihypertensive drugs. Hypertension 1993;21:810-5.
    • (1993) Hypertension , vol.21 , pp. 810-815
    • Erley, C.M.1    Haefere, U.2    Heyne, N.3    Braun, N.4    Risler, T.5
  • 11
    • 0035110009 scopus 로고    scopus 로고
    • Does treatment of non-malignant hypertension reduce the incidence of renal dysfunction? : A meta-analysis of 10 randomized, controlled trials
    • Hsu CY. Does treatment of non-malignant hypertension reduce the incidence of renal dysfunction? : A meta-analysis of 10 randomized, controlled trials. J Hum Hypertens 2001;15:99-106.
    • (2001) J Hum Hypertens , vol.15 , pp. 99-106
    • Hsu, C.Y.1
  • 12
    • 0035816018 scopus 로고    scopus 로고
    • Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: A randomized controlled trial
    • Agodoa LY, Appel L, Bakris GL, Beck G, Bourgoignie J, Briggs JP, et al. Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: A randomized controlled trial. JAMA 2001;285:2719-28.
    • (2001) JAMA , vol.285 , pp. 2719-2728
    • Agodoa, L.Y.1    Appel, L.2    Bakris, G.L.3    Beck, G.4    Bourgoignie, J.5    Briggs, J.P.6
  • 13
    • 0035922441 scopus 로고    scopus 로고
    • Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
    • Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving HH, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001;345:861-9.
    • (2001) N Engl J Med , vol.345 , pp. 861-869
    • Brenner, B.M.1    Cooper, M.E.2    De Zeeuw, D.3    Keane, W.F.4    Mitch, W.E.5    Parving, H.H.6
  • 14
    • 0035922447 scopus 로고    scopus 로고
    • Renoprotective effect of the angiotensin receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes
    • Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, et al. Renoprotective effect of the angiotensin receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 2001;345:851-60.
    • (2001) N Engl J Med , vol.345 , pp. 851-860
    • Lewis, E.J.1    Hunsicker, L.G.2    Clarke, W.R.3    Berl, T.4    Pohl, M.A.5    Lewis, J.B.6
  • 15
    • 0027461994 scopus 로고
    • Long-term effects of a converting enzyme inhibitor and a calcium channel blocker on urinary albumin excretion in patients with essential hypertension
    • Bigazzi R, Bianchi S, Baldari D, Sgherri G, Baldari G, Campese VM. Long-term effects of a converting enzyme inhibitor and a calcium channel blocker on urinary albumin excretion in patients with essential hypertension. Am J Hypertens 1993;6:108-13.
    • (1993) Am J Hypertens , vol.6 , pp. 108-113
    • Bigazzi, R.1    Bianchi, S.2    Baldari, D.3    Sgherri, G.4    Baldari, G.5    Campese, V.M.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.